idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project

idw-News App:


Google Play Store

26.10.2022 16:20

New factor in the development of hereditary kidney cancer discovered

Gabriele Meseg-Rutzen Kommunikation und Marketing
Universität zu Köln

    Scientists have identified the loss of the protein HIRA (histone cell cycle regulator) as a possible driving factor in a highly metastatic form of kidney cancer / study in ‘Science Advances’ opens up new perspectives for targeted therapies

    Deletion of the HIRA protein promotes the proliferation and invasion of tumour cells in cell culture and animal models. That is the result of a research endeavour led by Alexander von Humboldt Professor Dr Christian Frezza at the University of Cologne. The hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC) is based on a change in the gene that produces the protein fumarate hydratase (FH). Fumarate hydratase is a cell protein that is significantly involved in energy production in cells. However, the mutation in the gene alone does not lead to the disease. Other factors such as the reduced production of HIRA are necessary for cancer to develop, which the scientists discovered with the help of CRISPR/Cas9 screening in cells. The research, which was started at the MRC Cancer Unit of Cambridge University and completed at the CECAD Cluster of Excellence for Ageing Research at the University of Cologne, has now been published in Science Advances under the title ‘HIRA loss transforms FH-deficient cells’.
    ‘Based on these new mechanistic findings, a model for HLRCC kidney tumours can be developed that opens up new perspectives for targeted therapies,’ said Dr Lorea Valcarcel, first author of the study.
    In addition to the laboratory experiments, the scientists demonstrated a reduction in FH and HIRA proteins in affected HLRCC patients compared to samples from healthy individuals. Down-regulation of HIRA is also further confirmed by tumour biopsies from two patients compared to the normal surrounding tissue.
    Thus, loss of HIRA activates the protein MYC, a known oncogene. Oncogenes are genes and proteins that positively influence tumour formation through its function and activation of other proteins.
    Media Contact:
    Professor Dr Christian Frezza
    +49 221 478 84308
    Press and Communications Team:
    Dr Anna Euteneuer
    +49 221 470 1700
    Valcarcel-Jimenez L, Rogerson C, Yong C, Schmidt C, Yang M, Cremades-Rodelgo M, Harle V, Offord V, Wong K, Mora A, Speed A, Caraffini V, Tran MGB, Maher ER, Stewart GD, Vanharanta S, Adams DJ, Frezza C. HIRA loss transforms FH-deficient cells. Science Advances 2022


    Merkmale dieser Pressemitteilung:
    Biologie, Medizin



    Die Suche / Erweiterte Suche im idw-Archiv

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.


    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).


    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.


    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).